drugset / Trial / NCT00763204
A Phase I Study to Assess Novel Cream in a Psoriasis Plaque Test
RandomizedDouble-blindTreatment
Summary
The purpose of this study is to investigate dose-response relationship, antipsoriatic efficacy and safety of different concentrations of topical formulations with AN2728 in subjects with psoriasis vulgaris.
Timeline
- Start
- 2008-02-29
- Primary completion
- 2008-03-07
- Completion
- 2008-03-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Betamethasone | Other / unclassified | 0.1 % | Topical |
| Subject | Crisaborole | Small molecule | 0.03 % | Topical |
| Subject | Crisaborole | Small molecule | 0.3 % | Topical |
| Subject | Crisaborole | Small molecule | 1 % | Topical |
| Subject | Crisaborole | Small molecule | 2 % | Topical |